P10 Inc. insider sells $100,980 in company stock

In a recent move at P10, Inc. (NYSE:PX), an insider has sold a significant amount of company stock, according to the latest SEC filings. The transaction, which took place on September 19, 2024, involved the sale of 9,307 shares at a price of $10.85 per share, totaling $100,980.

The insider, identified as Nelson Andrew Rowan, is reported to have a connection to a group that holds more than 10% of P10, Inc.'s Common Stock. This sale has reduced Rowan's holdings in the company to 55,625 shares following the transaction. It is also noted that the shares were held directly by Rowan.

The sale price of $10.85 reflects the value investors were willing to pay for P10, Inc. shares at the time of the transaction. This price is a key figure for investors tracking insider behavior, as it provides insight into the value insiders assign to the stock.

The reporting person's connection to a significant ownership group may be of interest to investors, as it can indicate the insider's perspective on the company's current valuation and future prospects. However, the reasons behind Rowan's decision to sell at this price point have not been disclosed.

P10, Inc., based in Dallas, Texas, operates within the investment advice sector and is incorporated in Delaware. The company's shares are traded on the New York Stock Exchange under the ticker symbol PX.

This transaction was publicly disclosed as required by SEC regulations, which mandate that insiders report their trading activities in a timely manner. The details of the sale provide shareholders and potential investors with important information about insider sentiment and may be factored into their investment decisions.



In other recent news, P10 Inc (NYSE:PX ) has announced an agreement to acquire Madrid-based Qualitas Equity Funds for an initial $63 million, marking a significant expansion of P10's European presence. The transaction, which is expected to close in 2025, will add approximately $1 billion in fee-paying assets under management and expand P10's global client base by over 1,300 limited partners. In addition to this, P10 reported a strong second quarter in 2024, with revenue increasing by 14% to $71 million and substantial growth in fee-paying assets under management. However, UBS has downgraded P10's stock from Buy to Neutral, citing concerns about near-term earnings potential and valuation. These recent developments reflect a complex picture for P10, with strong revenue growth and strategic expansion on one hand, and concerns about near-term earnings and valuation on the other. Despite these challenges, P10 remains committed to its strategic focus on mergers and acquisitions and data utilization, positioning the firm for further growth and expansion into new markets and capabilities.
InvestingPro Insights


The latest data on P10, Inc. (NYSE:PX) from InvestingPro suggests a mixed financial outlook. With a market capitalization of $1.21 billion, the company is trading at a high earnings multiple, with a P/E ratio of 597.85. This indicates that investors have high expectations for future earnings growth, despite the company's current valuation being steep compared to its earnings. On a more positive note, P10, Inc.'s liquid assets exceed its short-term obligations, which may provide some reassurance to investors about the company's ability to meet its immediate financial commitments.

In terms of performance, P10, Inc. has experienced a strong return over the last three months, with a price total return of 32.02%. This large price uptick is also reflected over the last six months, with a total return of 34.22%. These metrics suggest that the company's stock has been gaining traction in the market, which could be a sign of growing investor confidence.

InvestingPro Tips highlight that analysts predict P10, Inc. will be profitable this year, which aligns with the positive return figures. However, it's important to note that four analysts have revised their earnings estimates downwards for the upcoming period. This could indicate potential concerns about the company's ability to meet market expectations in the near future. For those interested in deeper analysis, there are additional InvestingPro Tips available on the platform, providing a more comprehensive view of P10, Inc.'s financial health and future prospects.

For investors considering P10, Inc. as part of their portfolio, these insights may be valuable in assessing the company's current position and future potential. With the insider sale by Nelson Andrew Rowan, understanding the broader financial context through metrics like these can be particularly important. To explore further, additional InvestingPro Tips can be found at: https://www.investing.com/pro/PX

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com